Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.

Oncotarget - 10 May 2016

Brachtel Elena F, Operaña Theresa N, Sullivan Peggy S, Kerr Sarah E, Cherkis Karen A, Schroeder Brock E, Dry Sarah M, Schnabel Catherine A

Abstract excerpt

BACKGROUND: Detailed molecular evaluation of cytology and limited tissue samples is increasingly becoming the standard for cancer care. Reproducible and accurate diagnostic approaches with reduced demands on cellularity are an ongoing unmet need. This study evaluated the performance of a 92-gene assay for molecular diagnosis of tumor type/subtype in cytology and limited tissue samples. METHODS: Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytodiagnosis

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasms

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 27034010
DOI: 10.18632/oncotarget.8449
PMCID: PMC5053644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.PMID 27034010Read ↗

Gene expression profiling for the diagnosis of multiple primary malignant tumorsSemantic proximity Read ↗

Gene Expression Profiling for the Diagnosis of Multiple Primary Malignant TumorsSemantic proximity Read ↗

Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patientsSemantic proximity Read ↗

Advancing Precision Oncology: Whole-Exome Sequencing in Endometrial Cancer Liquid-Based Cytology.Semantic proximity Read ↗

Overview of Molecular Testing of Cytology SpecimensSemantic proximity Read ↗

Molecular Classification of Human Cancers Using a 92‐Gene Real-Time Quantitative Polymerase Chain Reaction AssaySemantic proximity Read ↗

Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility.Semantic proximity Read ↗

Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.Semantic proximity Read ↗

Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.Semantic proximity Read ↗

Validation of a Gene-Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive SeriesSemantic proximity Read ↗

Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility.Semantic proximity Read ↗

A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological SpecimensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.